Dating sites secured by verisign
Sola was the lead Nigerian counterpart managing the partnership with Stanford CDR and working to set up the organization and facilitate programs.
Sola's past work experience has been in the field of management consulting, working for Accenture and Dalberg Global Development Advisors.
Imraan earned an MBA from Columbia Business School, where he was an In SITE Fellow and a member of Foundation Capital’s Young Entrepreneurs Program.
He graduated with a BS in finance from the University of Maryland, College Park, where he was a Quest Honors Program Fellow.
Ben is a graduate of Duke University's Pratt School of Engineering, graduating with a bachelor's degree with dual majors in civil & environmental engineering and public policy studies.
Ben serves or has served on a number of non-profit boards, including the Chordoma Foundation, FACE AIDS, and the Duke University Board of Trustees. Jan joined EMBL Ventures in 2002 and is now a Managing Director with the firm, focusing on opportunities in the life science and medical device sectors.
Prior to Atlantis, Imraan was an associate at New Heritage Capital, a sector-agnostic, Boston-based private equity firm investing in founder and family-owned businesses.
Imraan began his career in investment banking, having completed the analyst program with Merrill Lynch’s M&A Group.
DF is a platform for individuals who want to launch initiatives (for-profit and nonprofit) to solve education challenges and be financially sustainable.
Earlier, Sola was the Nigerian project coordinator for The Institute for Venture Design (IVD or The Institute), a partnership between Stanford’s Centre for Design Research (CDR) and the FATE Foundation.
The Institute aims to increase the level of innovation and technological development in Nigeria through the incubation and building up of a culture of entrepreneurs, innovators, and risk takers.
He has been representing the firm on various portfolio boards including Endoart Medical Technology, Lipid Therapeutics, Allercra Therapeutics, and Opsona Therapeutics. Clevson, a boutique investment firm with offices in Nigeria and London that invests in African startups.
Prior to joining EMBL Ventures, Jan was a postdoctoral fellow of the Ernst Schering Research Foundation at the University of Granada, Spain, where his research focused on stem cells. The firm's investment model aims to generate wealth that contributes to economic development.As the second employee of this fund, Ben assisted its founder, Steve Westly, in raising 7 million in their first institutional fund.